Profile cover photo
Profile photo
Prostate Cancer Foundation
Prostate Cancer Foundation's posts

Post has attachment
04.25.2013 | Research News

Zytiga is Most Used First-Line Treatment for Stage IV Prostate Cancer

Market data released this week shows the new drug’s share of the first-line prostate cancer market has steadily increased to 30 percent since its launch in 2011. The development of this novel new treatment was supported by PCF-funded research.

Post has attachment
On November 8, 2011 the Prostate Cancer Foundation submitted comments in response to the U.S. Preventive Services Task Force’s (USPSTF) request to review their 2011 draft Recommendation Statement against prostate-specific antigen (PSA)-based screening for prostate cancer. Read them here:
Wait while more posts are being loaded